Your Cancer Care Team
SCRI Oncology Partners is committed to bringing clinical trials and pioneering therapies directly to you. As a cancer treatment center led by globally recognized oncologists with specialized expertise in cancer care, we provide comprehensive, cutting-edge care that is accessible and ready for you when you need it most.
Search by doctor name, gender, or specialty
More Filters
Our experienced team
Deepak Bhamidipati, MD
Gastrointestinal cancer, Early-phase drug development, Clinical research
Nashville, Tennessee 37203
Benjamin Garmezy, MD
Genitourinary cancers, including prostate, kidney, bladder and testicular, Clinical trials and research advancements, Early-phase drug development
Nashville, Tennessee 37203
Erika Hamilton, MD
Breast cancer, Clinical trials and research advancements, Cancers related to women’s health, Early-phase drug development
Nashville, Tennessee 37203
Melissa Johnson, MD
Lung cancer, Clinical trials and research advancements, Early-phase drug development
Nashville, Tennessee 37203
Hans Lee, MD
Multiple Myeloma, AL Amyloidosis, Waldenström Macroglobulinemia, Immune Effector Cell Therapy, Clinical Research
Nashville, Tennessee 37203
Mark Cooper, MD, FACS
Breast surgery, Benign and malignant breast disease, Genetic counseling, High-risk counseling, Oncoplastics, Sentinel node mapping
Nashville, Tennessee 37203
Meredith McKean, MD, MPH
Melanoma, Skin cancer, Clinical trials and research advancements, Early-phase drug development
Nashville, Tennessee 37203
Krish Patel MD
Lymphoma, Chronic Lymphocytic Leukemia, Immunotherapy, Early-phase drug development, Clinical research
Nashville, Tennessee 37203
Meredith Pelster, MD, MSCI
Gastrointestinal cancers, Head and neck cancers, Clinical trials and research advancement, Early-phase drug development
Nashville, Tennessee 37203
David Spigel, MD
Lung cancer, Early-phase drug development, Clinical research
Nashville, Tennessee 37203
Vivek Subbiah, MD
Endocrine cancer, Precision oncology, Sarcoma cancer, Targeted therapy and immunotherapy, Clinical trials and research advancements
Nashville, Tennessee 37203
Denise Yardley, MD
Breast cancer, Benign-hematology, Clinical trials and research advancements
Nashville, Tennessee 37203
Deepak Bhamidipati, MD
Nashville, Tennessee 37203
Gastrointestinal cancer, Early-phase drug development, Clinical research
Benjamin Garmezy, MD
Nashville, Tennessee 37203
Genitourinary cancers, including prostate, kidney, bladder and testicular, Clinical trials and research advancements, Early-phase drug development
Erika Hamilton, MD
Nashville, Tennessee 37203
Breast cancer, Clinical trials and research advancements, Cancers related to women’s health, Early-phase drug development
Melissa Johnson, MD
Nashville, Tennessee 37203
Lung cancer, Clinical trials and research advancements, Early-phase drug development
Cody Lebeck Lee, MD
Nashville, Tennessee 37203
General Hematology, Oncology
Hans Lee, MD
Nashville, Tennessee 37203
Multiple Myeloma, AL Amyloidosis, Waldenström Macroglobulinemia, Immune Effector Cell Therapy, Clinical Research
Mark Cooper, MD, FACS
Nashville, Tennessee 37203
Breast surgery, Benign and malignant breast disease, Genetic counseling, High-risk counseling, Oncoplastics, Sentinel node mapping
Meredith McKean, MD, MPH
Nashville, Tennessee 37203
Melanoma, Skin cancer, Clinical trials and research advancements, Early-phase drug development
Krish Patel MD
Nashville, Tennessee 37203
Lymphoma, Chronic Lymphocytic Leukemia, Immunotherapy, Early-phase drug development, Clinical research
Meredith Pelster, MD, MSCI
Nashville, Tennessee 37203
Gastrointestinal cancers, Head and neck cancers, Clinical trials and research advancement, Early-phase drug development
David Spigel, MD
Nashville, Tennessee 37203
Lung cancer, Early-phase drug development, Clinical research
Vivek Subbiah, MD
Nashville, Tennessee 37203
Endocrine cancer, Precision oncology, Sarcoma cancer, Targeted therapy and immunotherapy, Clinical trials and research advancements
Denise Yardley, MD
Nashville, Tennessee 37203
Breast cancer, Benign-hematology, Clinical trials and research advancements
Advance practice providers
Gretchen Drake, FNP-C, AOCNP
Early phase drug development of all solid tumor types, Clinical research
Nashville, Tennessee 37203
Katie Estopinal, MSN, AG-ACNP-BC, AOCNP
Early-phase drug development, Genitourinary oncology
Nashville, Tennessee 37203
Sharon Hale, ACNP
Breast cancer, Lung cancer, Early-phase drug development, Clinical research
Nashville, Tennessee 37203
Kayla Hobbs, FNP-BC
Gastrointestinal cancer, Head and neck cancers, Early-phase drug development, Clinical research
Nashville, Tennessee 37203
Laura Hollis, ACNP, BC
Lung cancer, early phase drug development
Nashville, Tennessee 37203
Melissa Kincade, MS, FNP-C
Gastrointestinal cancer, Head and neck cancers, Early-phase drug development, Clinical research
Nashville, Tennessee 37203
Alexis Lee, FNP-BC
Lung cancer, Head and neck cancers, Early-phase drug development, Clinical research
Nashville, Tennessee 37203
Kelsey Martin, APRN, AOCNP
Breast cancer, Gynecologic cancer, Early-phase drug development, Clinical research
Nashville, Tennessee 37203
Tricia Morris, ANP-BC, AOCNP
Breast cancer, Benign hematology, Early-phase drug development, Clinical research
Nashville, Tennessee 37203
Sarah Purcell, NP
Palliative care, Early-phase drug development, Clinical research
Nashville, Tennessee 37203
Melissa Rikal, FNP-BC, AOCNP
Breast cancer, Early-phase drug development, Clinical research
Nashville, Tennessee 37203
Erin Shoates, FNP-BC, AOCNP
Melanoma and other skin cancers, Early-phase drug development, Clinical research
Nashville, Tennessee 37203
Recent Articles
Six Must-Knows about Bladder Cancer
Bladder cancer is the fourth most common cancer diagnosed in men, and men are four times more likely than women to develop it.
What is Metastatic Breast Cancer?
Metastatic breast cancer is breast cancer that has spread from the breast to other parts of the body. This is also referred to as advanced or stage 4 breast cancer.
What is Biomarker Testing for Lung Cancer?
Biomarkers are proteins, hormones, or pieces of DNA that can be released by cancer cells or by your body in response to cancer, which may be tested for.
Contact Us
Whether you are newly diagnosed, previously treated or seeking additional care or research options, we are here to support you every step of the way.
Contact Us
Whether you are newly diagnosed, previously treated or seeking additional care or research options, we are here to support you every step of the way.
Contact Us
Whether you are newly diagnosed, previously treated or seeking additional care or research options, we are here to support you every step of the way.